Join to View Full Profile
500 S Henderson StSte 200Fort Worth, TX 76104
Phone+1 817-413-1500
Fax+1 817-413-1788
Dr. Oommen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sanjay Oommen is a practicing oncologist in Fort Worth, TX, with specializations in hematology, urologic oncology, and medical oncology. He received his education at the University of Minnesota, Texas Tech University HSC El Paso, and Kasturba Medical College Manipal. Over his career, Dr. Oommen has contributed to research with several publications in respected journals, including The Oncologist and Clinical Breast Cancer. He has also participated in clinical trials on therapeutics for advanced and hormone receptor-positive breast cancer. In 2012, he was recognized with the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 2005 - 2008
Texas Tech University HSC El PasoResidency, Internal Medicine, 2001 - 2004
Kasturba Medical College ManipalClass of 1995
Certifications & Licensure
TX State Medical License 2005 - 2026
MN State Medical License 2005 - 2008
NM State Medical License 2004 - 2006
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer Start of enrollment: 2013 Dec 17
- A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2014 Jul 22
Publications & Presentations
PubMed
- 12 citationsEvaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus‐Associated Stomatitis: A Randomized Phase II StudyVicky E. Jones, Kristi McIntyre, Devchand Paul, Sharon Wilks, Sharon M. Ondreyco
The Oncologist. 2019-09-01 - 29 citationsRamucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Ran...Denise A. Yardley, James Reeves, E. Claire Dees, Cynthia R. C. Osborne, Devchand Paul
Clinical Breast Cancer. 2016-12-01 - 8 citationsMalignant hyperthermia associated with diabetic hyperosmolar hyperglycemic nonketotic state in a young man.Amir Baluch, Sanjay P. Oommen
Journal of Clinical Anesthesia. 2007-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
